Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features (Q34450428)

2 August 2017

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features (English)

1 reference

2 August 2017

1 reference

2

Angela Dispenzieri

1 reference

2 August 2017

13

Robert A Kyle

1 reference

2 August 2017

6

Martha Q Lacy

1 reference

2 August 2017

14

S Vincent Rajkumar

1 reference

2 August 2017

15

Morie A Gertz

1 reference

2 August 2017

7

Suzanne R Hayman

1 reference

2 August 2017

8

Francis K Buadi

1 reference

2 August 2017

1

Shaji Kumar

1 reference

2 August 2017

3

Jerry A Katzmann

1 reference

2 August 2017

4

Dirk R Larson

1 reference

2 August 2017

12

Raynell J Clark

1 reference

2 August 2017

5

Colin L Colby

1 reference

2 August 2017

10

Steve R Zeldenrust

1 reference

PubMed ID

20798235

2 August 2017

Marina Ramirez-Alvarado

series ordinal

11

object named as

Marina Ramirez-Alvarado

1 reference

2 August 2017

Nelson Leung

9

1 reference

PubMed ID

20798235

2 August 2017

language of work or name

English

0 references

publication date

26 August 2010

1 reference

2 August 2017

4

1 reference

inferred from page(s)

published in

Blood

1 reference

2 August 2017

116

1 reference

2 August 2017

24

1 reference

2 August 2017

5126-5129

1 reference

Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myeloma

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012533

Screening panels for detection of monoclonal gammopathies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012533

Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012533

Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012533

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012533

Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012533

Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012533

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012533

Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012533

"Primary" systemic amyloidosis and myeloma. Discussion of relationship and review of 81 cases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012533

Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012533

Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012533

Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012533

Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012533

Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012533

Amyloidosis: clinical, pathologic, and biochemical characteristics

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012533

Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012533

Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3012533

Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance.

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20798235

12 December 2020

inferred from PubMed ID database lookup

Diagnostic and prognostic utility of the serum free light chain assay in patients with AL amyloidosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20798235

12 December 2020

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/20798235

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1182/BLOOD-2010-06-290668

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

PubMed ID

20798235